Cytosorbents (CTSO) Misses Q2 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.63 million versus the consensus estimate of $9.42 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• RBC Capital Starts Shake Shack (SHAK) at Outperform
• JPMorgan Upgrades Yangzijiang Shipbuilding (YZJSGD:SP) (YSHLF) to Overweight
• ICICI Securities Starts Jain Resource Recycling (JAINREC:IN) at Buy (1)